News

Other news

Syndesi Therapeutics announces initiation of Phase I study of novel SV2A modulator, SDI‐118, in development for the treatment of cognitive impairment.

By JLABS

Read full story
Other news

Johnson & Johnson announces today on the first day of National Nurses week The Natural Nipple and Cincinnati Children’s as the award recipients in the Johnson & Johnson Nurses Innovate QuickFire Challenge

By JLABS

Read full story
Other news

Johnson & Johnson Innovation Announces Launch of JPOD @ Boston Digital Health Technology QuickFire Challenge

By JLABS

Read full story
Press release

Johnson & Johnson Innovation Announces Collaboration with National Academy of Medicine to Help People Live Longer, Healthier Lives

By JLABS

Read full story
JLABS @ Washington DC Launch
Press release
April 09th 2019 -

Johnson & Johnson Innovation and Children’s National Health System* to Launch JLABS @ Washington, DC at the new Children’s National Research and Innovation Campus in 2020

Read story
Other news

New Johnson & Johnson Nurses Innovate QuickFire Challenge in Perioperative Care launched at AORN Expo

By JLABS

Read full story
Other news

Syndesi Therapeutics Awarded Non-dilutive Funding of up to €3.2M for Development of its Lead Program, SDI-118, Aimed at Treating Cognitive Impairment

By JLABS

Read full story
Other news

Calypso Biotech BV secures 20 Million EUR in Series A Financing to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases

By JLABS

Read full story
Other news

Johnson & Johnson Innovation Names Swedish Medical Technology Company PExA Awardee in the Carcinogenic Exposure Meter Quickfire Challenge

By JLABS

Read full story
Other news

Johnson & Johnson Innovation Awards Bloomlife the First 1000 Days QuickFire Challenge

By JLABS

Read full story
In the media

Legacy Companies Look Outward to Find Innovation

By Techonomy

Read full story
In the media

JLABS Injects Some Tech into the Medical Industry

By Digital Trends

Read full story
Press release

Johnson & Johnson Innovation Announces Winners of the Seoul Innovation QuickFire Challenge: Robotics & Digital Surgery in Collaboration with Seoul Metropolitan Government and KHIDI

By JLABS

Read full story
Other news

Genome Biologics wins prestigious Horizon 2020 EU Phase 2 grant award

By JLABS

Read full story
Other news

Johnson & Johnson Innovation Announces Winner of the European Innovation QuickFire Challenge: AlphaBiomics

By JLABS

Read full story